Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
The agreement is the largest healthcare fraud settlement in history, spanning nearly every state, according to the Justice Department. It’s also the largest payment ever by a drug company.
